دورية أكاديمية
أعرض في EDS

Adolescent nicotine administration increases nicotinic acetylcholine receptor binding and functional connectivity in specific cortico-striatal-thalamic circuits.

التفاصيل البيبلوغرافية
العنوان: Adolescent nicotine administration increases nicotinic acetylcholine receptor binding and functional connectivity in specific cortico-striatal-thalamic circuits.
المؤلفون: Keeley RJ; National Institute on Drug Abuse, Intramural Research Program (NIDA-IRP), National Institutes of Health, Baltimore, MD 21224, USA., Prillaman ME; National Institute on Drug Abuse, Intramural Research Program (NIDA-IRP), National Institutes of Health, Baltimore, MD 21224, USA., Scarlata M; National Institute on Drug Abuse, Intramural Research Program (NIDA-IRP), National Institutes of Health, Baltimore, MD 21224, USA., Vrana A; National Institute on Drug Abuse, Intramural Research Program (NIDA-IRP), National Institutes of Health, Baltimore, MD 21224, USA., Tsai PJ; National Institute on Drug Abuse, Intramural Research Program (NIDA-IRP), National Institutes of Health, Baltimore, MD 21224, USA., Gomez JL; National Institute on Drug Abuse, Intramural Research Program (NIDA-IRP), National Institutes of Health, Baltimore, MD 21224, USA., Bonaventura J; National Institute on Drug Abuse, Intramural Research Program (NIDA-IRP), National Institutes of Health, Baltimore, MD 21224, USA.; Departament de Patologia Terapèutica Experimental, Institut de Neurociènes, Universitat de Barcelona, Gran Via de les Corts Catalanes, 585, 08007 Barcelona, Spain., Lu H; National Institute on Drug Abuse, Intramural Research Program (NIDA-IRP), National Institutes of Health, Baltimore, MD 21224, USA., Michaelides M; National Institute on Drug Abuse, Intramural Research Program (NIDA-IRP), National Institutes of Health, Baltimore, MD 21224, USA., Stein EA; National Institute on Drug Abuse, Intramural Research Program (NIDA-IRP), National Institutes of Health, Baltimore, MD 21224, USA.
المصدر: Brain communications [Brain Commun] 2022 Nov 19; Vol. 4 (6), pp. fcac291. Date of Electronic Publication: 2022 Nov 19 (Print Publication: 2022).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755125 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-1297 (Electronic) Linking ISSN: 26321297 NLM ISO Abbreviation: Brain Commun Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Oxford] : Oxford University Press, [2019]-
مستخلص: Nicotine exposure is associated with regional changes in brain nicotinic acetylcholine receptors subtype expression patterns as a function of dose and age at the time of exposure. Moreover, nicotine dependence is associated with changes in brain circuit functional connectivity, but the relationship between such connectivity and concomitant regional distribution changes in nicotinic acetylcholine receptor subtypes following nicotine exposure is not understood. Although smoking typically begins in adolescence, developmental changes in brain circuits and nicotinic acetylcholine receptors following chronic nicotine exposure remain minimally investigated. Here, we combined in vitro nicotinic acetylcholine receptor autoradiography with resting state functional magnetic resonance imaging to measure changes in [ 3 H]nicotine binding and α4ß2 subtype nicotinic acetylcholine receptor binding and circuit connectivity across the brain in adolescent (postnatal Day 33) and adult (postnatal Day 68) rats exposed to 6 weeks of nicotine administration (0, 1.2 and 4.8 mg/kg/day). Chronic nicotine exposure increased nicotinic acetylcholine receptor levels and induced discrete, developmental stage changes in regional nicotinic acetylcholine receptor subtype distribution. These effects were most pronounced in striatal, thalamic and cortical regions when nicotine was administered during adolescence but not in adults. Using these regional receptor changes as seeds, resting state functional magnetic resonance imaging identified dysregulations in cortico-striatal-thalamic-cortical circuits that were also dysregulated following adolescent nicotine exposure. Thus, nicotine-induced increases in cortical, striatal and thalamic nicotinic acetylcholine receptors during adolescence modifies processing and brain circuits within cortico-striatal-thalamic-cortical loops, which are known to be crucial for multisensory integration, action selection and motor output, and may alter the developmental trajectory of the adolescent brain. This unique multimodal study significantly advances our understanding of nicotine dependence and its effects on the adolescent brain.
(Published by Oxford University Press on behalf of the Guarantors of Brain 2022. This work is written by (a) US Government employee(s) and is in the public domain in the US.)
References: Biol Psychiatry. 2013 Oct 1;74(7):538-46. (PMID: 23506999)
J Consult Clin Psychol. 1996 Oct;64(5):993-1002. (PMID: 8916628)
J Addict Res Ther. 2011 Apr 20;S1(1):. (PMID: 22454789)
Brain Res. 1999 Dec 18;851(1-2):9-19. (PMID: 10642823)
Drug Alcohol Depend. 2006 Oct 1;84(3):231-9. (PMID: 16574343)
Pharmacol Biochem Behav. 2016 Mar;142:79-84. (PMID: 26751248)
J Neurosci. 2014 Jul 16;34(29):9497-505. (PMID: 25031393)
Psychopharmacology (Berl). 2006 Mar;184(3-4):314-27. (PMID: 16001112)
Brain Res Bull. 2009 Feb 16;78(2-3):69-74. (PMID: 18950692)
J Adolesc Health. 2013 Feb;52(2 Suppl 2):S7-13. (PMID: 23332574)
Proc Natl Acad Sci U S A. 2012 Mar 6;109(10):3979-84. (PMID: 22355129)
Neuroimage. 2011 Jan 1;54(1):42-8. (PMID: 20699124)
J Neurosci. 1999 Jun 15;19(12):4804-14. (PMID: 10366615)
J Pharmacol Exp Ther. 2007 Jul;322(1):399-407. (PMID: 17446302)
J Neurobiol. 2002 Dec;53(4):457-78. (PMID: 12436413)
Nicotine Tob Res. 1999;1 Suppl 2:S149-52; discussion S165-6. (PMID: 11768173)
Dev Psychobiol. 2016 Jul;58(5):660-6. (PMID: 27027859)
Biol Psychiatry Cogn Neurosci Neuroimaging. 2018 Feb;3(2):150-159. (PMID: 29529410)
Neuropsychopharmacology. 2016 Sep;41(10):2557-65. (PMID: 27112116)
J Neurosci. 2006 Aug 9;26(32):8368-76. (PMID: 16899732)
Biol Psychiatry. 2017 Apr 1;81(7):554-563. (PMID: 27865452)
Proc Natl Acad Sci U S A. 2010 Jul 27;107(30):13509-14. (PMID: 20643934)
Brain Res. 2008 Jun 18;1215:40-52. (PMID: 18474362)
J Neurosci. 2007 Feb 28;27(9):2349-56. (PMID: 17329432)
J Pharmacol Exp Ther. 2008 Apr;325(1):302-12. (PMID: 18184829)
JAMA. 2015 Aug 18;314(7):700-7. (PMID: 26284721)
Neuropsychopharmacology. 2014 Oct;39(11):2594-600. (PMID: 24832823)
Nat Rev Neurosci. 2010 Jun;11(6):389-401. (PMID: 20485364)
Life Sci. 1987 Apr 27;40(17):1699-708. (PMID: 3561170)
Brain Res. 2015 Dec 2;1628(Pt A):104-16. (PMID: 25514336)
J Physiol. 2015 Aug 15;593(16):3397-412. (PMID: 26018031)
Neuropharmacology. 2020 Dec 15;181:108308. (PMID: 32950561)
Lancet Psychiatry. 2014 Dec;1(7):549-58. (PMID: 26361314)
J Neurosci. 2001 Mar 15;21(6):1819-29. (PMID: 11245666)
Dialogues Clin Neurosci. 2016 Mar;18(1):7-21. (PMID: 27069376)
Neurotoxicol Teratol. 2007 Jan-Feb;29(1):74-80. (PMID: 17095188)
Neuropsychopharmacology. 2020 May;45(6):1042-1049. (PMID: 32053829)
Psychopharmacology (Berl). 1999 Jan;141(2):145-53. (PMID: 9952038)
J Physiol. 1982 Jan;322:257-72. (PMID: 6978400)
Curr Opin Neurobiol. 2013 Aug;23(4):581-7. (PMID: 23428657)
Pharmacol Biochem Behav. 1992 Nov;43(3):779-84. (PMID: 1448472)
Nat Methods. 2012 Jun 28;9(7):676-82. (PMID: 22743772)
Eur J Pharmacol. 2000 Mar 30;393(1-3):31-8. (PMID: 10770995)
Prog Neurobiol. 2015 Jan;124:1-27. (PMID: 25447802)
Front Syst Neurosci. 2010 May 18;4:10. (PMID: 20514143)
J Neurosci. 1985 May;5(5):1307-15. (PMID: 3998824)
J Mol Neurosci. 1999 Aug-Oct;13(1-2):31-45. (PMID: 10691290)
Neuropsychopharmacology. 2014 Jul;39(8):1816-22. (PMID: 24584328)
Neuropsychopharmacology. 2008 Aug;33(9):2158-66. (PMID: 18033235)
J Neurosci. 2000 Sep 1;20(17):6431-41. (PMID: 10964949)
J Neurosci. 2019 Jun 19;39(25):5028-5037. (PMID: 30992371)
Brain Res. 2000 Jun 9;867(1-2):29-39. (PMID: 10837795)
Biol Psychiatry. 2020 Dec 1;88(11):867-878. (PMID: 32981657)
EMBO J. 1999 Mar 1;18(5):1235-44. (PMID: 10064590)
JAMA Psychiatry. 2014 May;71(5):523-30. (PMID: 24622915)
Magn Reson Med. 1995 Oct;34(4):537-41. (PMID: 8524021)
Curr Opin Psychiatry. 2007 Jul;20(4):359-64. (PMID: 17551351)
Comput Biomed Res. 1996 Jun;29(3):162-73. (PMID: 8812068)
Synapse. 2008 Mar;62(3):159-68. (PMID: 18081183)
Arch Gen Psychiatry. 2005 Jun;62(6):593-602. (PMID: 15939837)
Addict Biol. 2015 Mar;20(2):377-89. (PMID: 24354662)
Eur J Neurosci. 2019 Mar;49(5):604-622. (PMID: 29797362)
Ann N Y Acad Sci. 2008 Mar;1124:111-26. (PMID: 18400927)
Subst Abuse Rehabil. 2013 Feb 08;4:29-43. (PMID: 24648786)
Nature. 1972 Apr 7;236(5345):308-10. (PMID: 4552162)
Neuroimage. 2004;23 Suppl 1:S208-19. (PMID: 15501092)
Brain Res. 2000 Dec 29;887(2):399-405. (PMID: 11134630)
Arch Gen Psychiatry. 2006 Aug;63(8):907-15. (PMID: 16894067)
Eur J Neurosci. 1999 Jan;11(1):18-30. (PMID: 9987008)
Brain Res. 2004 Dec 24;1030(1):159-63. (PMID: 15567348)
J Neurosci. 1992 Jul;12(7):2765-84. (PMID: 1613557)
Br J Pharmacol. 1995 Jan;114(2):454-60. (PMID: 7881744)
J Am Acad Child Adolesc Psychiatry. 2010 Dec;49(12):1189-201; quiz 1285. (PMID: 21093769)
Biol Psychiatry. 2004 Jan 1;55(1):77-84. (PMID: 14706428)
Nature. 1998 Jan 8;391(6663):173-7. (PMID: 9428762)
Br J Pharmacol. 2018 Jun;175(11):1928-1943. (PMID: 29266170)
Neuroimage. 2011 Jan 1;54(1):131-41. (PMID: 20688176)
J Psychiatr Res. 2016 Dec;83:37-46. (PMID: 27552532)
Neurosci Biobehav Rev. 2003 Sep;27(4):351-63. (PMID: 12946688)
PLoS One. 2010 May 25;5(5):e10815. (PMID: 20520835)
Arch Gen Psychiatry. 2009 Apr;66(4):431-41. (PMID: 19349313)
J Neurochem. 2002 Aug;82(3):468-81. (PMID: 12153472)
Neuropsychopharmacology. 2017 Apr;42(5):1001-1011. (PMID: 27649640)
Lancet Psychiatry. 2016 Aug;3(8):760-773. (PMID: 27475769)
Brain Res. 1993 Jul 23;617(2):349-52. (PMID: 8402163)
Neuropsychopharmacology. 2019 Aug;44(9):1649-1658. (PMID: 31060043)
Neuron. 2006 Jun 15;50(6):911-21. (PMID: 16772172)
Neuroimage. 2017 Feb 1;146:821-832. (PMID: 27646127)
Neuroimage. 2012 Aug 15;62(2):743-7. (PMID: 21889996)
J Consult Clin Psychol. 1987 Jun;55(3):367-71. (PMID: 3597950)
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jun;4(6):522-532. (PMID: 30270095)
Cell Mol Life Sci. 2014 Apr;71(7):1225-44. (PMID: 24122021)
Synapse. 2010 May;64(5):397-402. (PMID: 20034014)
Annu Rev Neurosci. 1986;9:357-81. (PMID: 3085570)
Neuron. 2012 Oct 4;76(1):116-29. (PMID: 23040810)
Trends Neurosci. 2011 Jul;34(7):383-92. (PMID: 21696833)
J Biol Chem. 2012 Nov 23;287(48):40207-15. (PMID: 23038257)
Psychopharmacology (Berl). 2006 Jul;186(4):612-9. (PMID: 16598454)
Handb Exp Pharmacol. 2009;(192):29-60. (PMID: 19184645)
J Neurochem. 2010 Aug;114(4):1205-16. (PMID: 20533993)
J Neurochem. 2001 Sep;78(6):1367-78. (PMID: 11579145)
Neuropharmacology. 2020 Oct 15;177:108256. (PMID: 32738308)
Pharmacol Biochem Behav. 2019 Dec;187:172802. (PMID: 31669000)
Biochem Pharmacol. 2011 Oct 15;82(8):828-41. (PMID: 21575611)
فهرسة مساهمة: Keywords: adolescence; brain circuits; fMRI; nAChR autoradiography; nicotine
تواريخ الأحداث: Date Created: 20221128 Latest Revision: 20221129
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC9683397
DOI: 10.1093/braincomms/fcac291
PMID: 36440101
قاعدة البيانات: MEDLINE
الوصف
تدمد:2632-1297
DOI:10.1093/braincomms/fcac291